These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6019224)

  • 41. [Diagnostic value of chymotrypsin and trypsin activity determination in the feces in the diagnosis of pancreatic disease].
    Zurakowski J; Dzieniszewski J; Hertel Z
    Pol Tyg Lek; 1976 May; 31(22):953-5. PubMed ID: 951261
    [No Abstract]   [Full Text] [Related]  

  • 42. Fecal chymotrypsin and trypsin determinations.
    Smith JS; Ediss I; Mullinger MA; Bogoch A
    Can Med Assoc J; 1971 Apr; 104(8):691-4 passim. PubMed ID: 5550376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stool chymotrypsin activity measured by a spectrophotometric procedure to identify pancreatic disease in infants.
    Remtulla MA; Durie PR; Goldberg DM
    Clin Biochem; 1986 Dec; 19(6):341-7. PubMed ID: 3581468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
    Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
    Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoreactive trypsin, chymotrypsin, and pancreatic secretory trypsin inhibitor in cord blood from infants with cystic fibrosis.
    Borgström A; Sveger T; Lindberg T; Kullander S; Svanberg L
    Acta Paediatr Scand; 1981 Sep; 70(5):619-21. PubMed ID: 7324908
    [No Abstract]   [Full Text] [Related]  

  • 46. Fecal fat and nitrogen in healthy children and in children with malabsorption or maldigestion.
    Shmerling DH; Forrer JC; Prader A
    Pediatrics; 1970 Nov; 46(5):690-5. PubMed ID: 5481070
    [No Abstract]   [Full Text] [Related]  

  • 47. Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: a collaborative study of the Italian Society of Pediatric Gastroenterology and Hepatology.
    Carroccio A; Verghi F; Santini B; Lucidi V; Iacono G; Cavataio F; Soresi M; Ansaldi N; Castro M; Montalto G
    Dig Dis Sci; 2001 Jun; 46(6):1335-42. PubMed ID: 11414313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of immunoreactive trypsin, pancreatic elastase and chymotrypsin in extracts of human feces and ileostomy drainage.
    Bohe M; Borgström A; Genell S; Ohlsson K
    Digestion; 1983; 27(1):8-15. PubMed ID: 6554206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stool chymotrypsin and trypsin determinations.
    Adham NF; Dyce BJ; Geokas MC; Haverback BJ
    Am J Dig Dis; 1967 Dec; 12(12):1272-6. PubMed ID: 6075726
    [No Abstract]   [Full Text] [Related]  

  • 50. [Differential-diagnostic value of estimation of fecal lipids in malabsorption syndromes].
    Tabolin VA; Mukhina IuG; Korneva TI; Chuĭchenko SS
    Pediatriia; 1982 Oct; (10):56-7. PubMed ID: 7177750
    [No Abstract]   [Full Text] [Related]  

  • 51. Cystic fibrosis screening in the newborn.
    Robinson PG; Elliot RB
    Arch Dis Child; 1976 Apr; 51(4):301-4. PubMed ID: 1275544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. QUANTITATIVE DETERMINATION OF FECAL TRYPSIN AND CHYMOTRYPSIN: A SCREENING TEST FOR PANCREATIC EXOCRINE INSUFFICIENCY.
    DYCK W; AMMANN R; ROSENMUND H
    Acta Gastroenterol Belg; 1964 Nov; 27():590-6. PubMed ID: 14266814
    [No Abstract]   [Full Text] [Related]  

  • 53. Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis.
    Weber AM; Roy CC; Chartrand L; Lepage G; Dufour OL; Morin CL; Lasalle R
    Gut; 1976 Apr; 17(4):295-9. PubMed ID: 773791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Levels of trypsin and alpha-chymotrypsin in feces from patients with Crohn's disease.
    van de Merwe JP; Mol GJ
    Digestion; 1982; 24(1):1-4. PubMed ID: 7128947
    [No Abstract]   [Full Text] [Related]  

  • 55. Fecal elastase-1 determination: 'gold standard' of indirect pancreatic function tests?
    Lüth S; Teyssen S; Forssmann K; Kölbel C; Krummenauer F; Singer MV
    Scand J Gastroenterol; 2001 Oct; 36(10):1092-9. PubMed ID: 11589385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fecal elastase-1: a useful test in pediatric practice].
    David-Henriau L; Bui S; Molinari I; Montaudon D; Lamireau T
    Arch Pediatr; 2005 Aug; 12(8):1221-5. PubMed ID: 16051075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal follow-up of exocrine pancreatic function in pancreatic sufficient cystic fibrosis patients using the fecal elastase-1 test.
    Walkowiak J; Nousia-Arvanitakis S; Agguridaki C; Fotoulaki M; Strzykala K; Balassopoulou A; Witt M; Herzig KH
    J Pediatr Gastroenterol Nutr; 2003 Apr; 36(4):474-8. PubMed ID: 12658038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malabsorption.
    Holzel A
    Midwife Health Visit Community Nurse; 1978 Mar; 14(3):79-81. PubMed ID: 245537
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hypoplasia of exocrine pancreas. Associated myoendocardial fibrosis in 1 of 2 brothers].
    Sacrez R; Klein F; Hoffmann B; Lévy JM; Geisert J; Korn R
    Ann Pediatr (Paris); 1969 Jan; 16(1):43-8. PubMed ID: 5791874
    [No Abstract]   [Full Text] [Related]  

  • 60. Bile acid malabsorption in cystic fibrosis.
    Nutr Rev; 1974 Aug; 32(8):232-4. PubMed ID: 4602696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.